influential [idcn]
calcium antagonist [phsu]
Survival [acty]
Patients [podg]
treated [topp]
coronary angioplasty [topp]
Meta-Analysis [inpr]
Reported [inpr]
Nifedipine [orch, phsu]
Increased [qnco]
Mortality [qnco]
Dose [qnco]
Patients [podg]
coronary artery disease [dsyn]
Few [qnco]
Asians [popg]
Patients [podg]
treated [topp]
calcium antagonist [phsu]
Successful [qlco]
coronary angioplasty [topp]
ptca [topp]
Subject [grup]
Consecutive [qlco]
Patients [podg]
Males [fndg]
Aged [orga]
Successful [qlco]
ELECTIVE [topp]
ptca [topp]
divided [ftcn]
Group [idcn]
calcium antagonist [phsu]
Group [idcn]
N NOS [aapp, imft]
calcium antagonist [phsu]
Group [idcn]
N NOS [aapp, imft]
Evaluated [ftcn]
Survival [acty]
cardiac events [dsyn]
Second [qnco]
calcium antagonist [phsu]
Group [idcn]
divided [ftcn]
4 groups [inpr]
calcium antagonist [phsu]
i e [diap, inpr]
short [qlco]
Nifedipine [orch, phsu]
Group [idcn]
N NOS [aapp, imft]
Long [qlco]
ACT [topp]
Nifedipine [orch, phsu]
Group [idcn]
N NOS [aapp, imft]
Diltiazem [orch, phsu]
Group [idcn]
N NOS [aapp, imft]
Group [idcn]
N NOS [aapp, imft]
Group [idcn]
Evaluated [ftcn]
Same [qlco]
Primary Endpoint [irda]
Set [menp]
secondary [neop]
End Point [qlco]
cardiac events [dsyn]
Including [ftcn]
Fatal [qlco]
Acute myocardial infarction [dsyn]
Coronary Artery Bypass Surgery [topp]
Repeat [ftcn]
ptca [topp]
Performed [ftcn]
Proportional Hazard Model [inpr, qnco]
Kaplan-Meier Analysis [qnco]
calcium antagonist [phsu]
Group [idcn]
worse [qlco]
Prognoses [hlca]
calcium antagonist [phsu]
Group [idcn]
P NOS [aapp, imft]
Prognoses [hlca]
calcium antagonist [phsu]
Group [idcn]
Revealed [qlco]
calcium antagonist [phsu]
Independent [idcn]
Contributing [acty]
calcium antagonist [phsu]
Mortality [qnco]
Patients [podg]
Successful [qlco]
ELECTIVE [topp]
ptca [topp]
Contribute [acty]
Favorable [qlco]
